An observational study in Headache and Nasal Airway, sponsored by Adana City Training and Research Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 5 Years to 10 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by Adana City Training and Research Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 64 studies in Headache with a site in Turkey — 9 open to participants now, 10 under way, none of them phase 3. Headache · Turkey.
Among the 64 studies in Headache with a site in Turkey, this one has the largest enrollment of the 28 observational ones that give a count, is one of 5 that started in 2026, is one of 28 observational ones, and was the 64th registered.
764 studies on the registry are indexed under Headache; 134 are open to participants now.
Browse Headache studies →9 of the 64 studies in Headache with a site in Turkey are open now. Recruiting first, the newest first:
Amasya University · Sites in Turkey
Ages 18–45 · Women only
Bartın Unıversity · Sites in Turkey
Ages 18+ · Healthy volunteers
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey · Sites in Turkey
Ages 18–65 · Women only
Hospital Universitari Vall d'Hebron Research Institute · Sites in Turkey, United States, Argentina and 10 more countries
Ages 18+
Aydin Adnan Menderes University · Sites in Turkey
Ages 18–60
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 83 Headache studies recruiting now, 30 (36%) set no upper age limit and 44 (53%) stop at 75 or younger; 10 take children under 18; 14 take healthy volunteers.
This study: 5 Years to 10 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
64 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 5 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 1,323 is above the median of 145 across 168 observational studies indexed under Headache.
Median enrollment 60 across the 36 interventional studies, 141 across the 28 observational. Of the 45 that completed or were terminated, 4 (9%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 64 have an industry lead sponsor. The 10 most frequent:
Adana City Training and Research Hospital is the lead sponsor of 18 studies on the registry; 1 is open to participants now.
Adana City Training and Research Hospital has 1 study filed under Headache — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 64 studies in Headache with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Headaches in pediatric patients can be related to primary (essential) and secondary (symptomatic) causes. This study investigates the correlation between nasal dysfunction, specifically mucociliary clearance impairment and structural anomalies, and cephalalgia in children, with a focus on allergic rhinitis and rhinopathy. A total of 2,262 children aged 5 to 10 years were screened. Clinical evaluation included evaluation of headache history, nasal patency, mucociliary clearance function, and the presence of structural anomalies such as septal deviation or adenoidal hypertrophy. A significant association was found between nasal dysfunction and headache. Children with impaired mucociliary clearance, nasal obstruction, or structural abnormalities demonstrated a higher prevalence of cephalalgia compared to those with normal nasal function. Allergic rhinitis was frequently observed among patients who reported recurrent headaches. Altered nasal dysfunction appears to be an important and potentially underrecognized contributor to pediatric headache. These findings highlight the need for comprehensive Ear Nose Throat evaluation in children with recurrent and unexplained cephalalgia.
Among the enrolled participants, 126 children reported recurrent headache episodes and constituted the cephalalgia group, whereas the remaining 1,197 children served as the control group.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
recurrent headache
control
nasal airway conductance
Nasal airflow was assessed by active anterior rhinomanometry using a Rhino-Comp 4000 rhinomanometer (Homoth Medizinelektronik GmbH \& Co. KG, Hamburg, Germany). Nasal conductance was calculated as the ratio of nasal airflow to transnasal pressure and expressed in liters per minute per millimeter of water pressure (L/min/mmH₂O) for both nasal cavities.
Time frame: At the initial clinical assessment (baseline)
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No — Individual participant data (IPD) will not be publicly shared due to patient confidentiality, privacy considerations, and the inclusion of data from pediatric participants.
Ran from Jan 2026 to primary completion in Jan 2026, 0 months.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Adana City Training and Research Hospital